Alternative initiations with 6-monthly paliperidone palmitate. A retrospective study

نویسندگان

چکیده

Introduction 6-monthly paliperidone palmitate features an initiation regimen through 1-monthly or 3-monthly palmitate. Some patients do not have sufficient adherence to treatment and it is necessary at the clinical level start directly with There little experience these alternative initiations this work those that been carried out for 12 months Hospital Universitario Infanta Elena are exposed. Objectives The main objective of study describe performed in routine practice, having opted a different from standard reasons. Methods A retrospective selection will be made non-probabilistic consecutive sampling, including all who administered during last 4 months. To this, electronic medical record used, first selecting started anonymized digital records and, later, only followed pattern. variables studied following: age, sex, diagnosis, dose palmitate, regimen, consumption toxic substances, absenteeism visits emergency room admissions. Results included total 20 (n: 20). 80% were male 20% female. mean age was 39.7 years. 75% had associated substance use disorder. following alternate starting schedules biannual palmitate: monthly on days 1 8, day 38 11); 150 mg together semi-annual both 5); supplemented oral 45 (n:4). 0 department admissions observed after regimen. Conclusions Alternative may useful safe very low who, due needs, require earlier order guarantee adherence. Disclosure Interest None Declared

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PM480. Early schizophrenia patients treated with once-monthly paliperidone palmitate over a 12-month period - A Retrospective Observational Study

Background: Repeated administration of amphetamine elicits a progressive enhancement in behavioral and subjective responses to the drug and an increase in amphetamine-induced dopamine release. This enhancement is called sensitization and is able to induce changes in the response of the brain dopamine system to amphetamines mimicking certain aspects of dopaminergic dysfunction in schizophrenia. ...

متن کامل

A quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthly

Long-acting injectable (LAI) antipsychotic formulations are increasingly used for improving patient compliance and long-term outcomes. Transitioning to LAIs raises questions regarding how optimum efficacy can be rapidly achieved while minimizing potential efficacy and safety concerns related to overlapping plasma levels of prior treatments and the new LAI. Ideally, randomized clinical trials wo...

متن کامل

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Sexual dysfunction, a common side effect of antipsychotic medications, may be partly caused by dopamine antagonism and elevation of prolactin. In QUALIFY, a randomized study, aripiprazole once-monthly 400 mg (AOM 400), a dopamine D2 receptor partial agonist, showed noninferiority and subsequent superiority versus paliperidone palmitate (PP), a dopamine D2 receptor antagonist, on the Heinrichs-C...

متن کامل

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder

Data from a multiphase schizoaffective disorder study (NCT01193153) were used to examine the effects of paliperidone palmitate once-monthly (PP1M) by subjects' illness duration, defined as recent onset (≤5 years since first psychiatric diagnosis; n = 206) and chronic illness (>5 years; n = 461). Symptom and functioning scores, as measured during open-label PP1M acute and stabilization treatment...

متن کامل

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

BACKGROUND A post hoc analysis from a multiphase trial with open-label transition and maintenance phases, a double-blind relapse prevention phase, and an optional open-label extension examined the long-term tolerability with continuous once-monthly injectable paliperidone palmitate 39, 78, 117, or 156 mg (25, 50, 75, or 100 mg equivalents [mg eq] of paliperidone) in subjects with recently diagn...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Psychiatry

سال: 2023

ISSN: ['0924-9338', '1778-3585']

DOI: https://doi.org/10.1192/j.eurpsy.2023.1044